1715 — AI Health Technology Income Statement
0.000.00%
Last trade - 00:00- HK$187.60m
- HK$194.41m
- CNY91.89m
Annual income statement for AI Health Technology, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 189 | 144 | 88.2 | 84.4 | 91.9 |
| Cost of Revenue | |||||
| Gross Profit | 95 | 65.3 | 38.5 | 21.2 | 6.49 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 212 | 185 | 126 | 125 | 123 |
| Operating Profit | -22.4 | -41.6 | -37.8 | -41 | -31.5 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -19.7 | -43.7 | -43.2 | -49.3 | -36 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -19.9 | -43.9 | -43.5 | -49.3 | -36 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -21.1 | -44.4 | -43.2 | -49.3 | -35.9 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -21.1 | -44.4 | -43.2 | -49.3 | -35.9 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.308 | -0.647 | -0.688 | -0.63 | -0.325 |